Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Tiseo

Showing results (41-50 of 363) with videos related to

Pageof 37
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 29, 2020
COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitorsAlessandro Leonetti, Francesco Facchinetti, Teresa Zielli, et al.
Tumori|August 19, 2008
Refractory pleural small cell carcinoma in never smoker. A case reportMarcello Tiseo, Elena Spiritelli, Marzia Capelletti, et al.
Handbook of Experimental Pharmacology|March 24, 2017
Mechanisms of Resistance to Target Therapies in Non-small Cell Lung CancerFrancesco Facchinetti, Claudia Proto, Roberta Minari, et al.
Anticancer Research|June 13, 2014
Gefitinib and afatinib treatment in an advanced non-small cell lung cancer (NSCLC) patient undergoing hemodialysisMelissa Bersanelli, Marcello Tiseo, Fabrizio Artioli, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2021
Letter comments on: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expressionAlessandro Leonetti, Giulia C Giudice, Fabiana Perrone, et al.
Cells|February 15, 2022
Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung CancerKamal Eltayeb, Silvia La Monica, Marcello Tiseo, et al.
Cancers|July 27, 2024
Alectinib in Early-Stage Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Current Evidence and Future ChallengesDiego Luigi Cortinovis, Alessandro Leonetti, Alessandro Morabito, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
K-RAS mutations indicating primary resistance to crizotinib in ALK-rearranged adenocarcinomas of the lung: Report of two cases and review of the literatureMaria Cecilia Mengoli, Fausto Barbieri, Federica Bertolini, et al.
Translational Lung Cancer Research|July 23, 2021
Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysisGiorgia Guaitoli, Marcello Tiseo, Massimo Di Maio, et al.
Lung Cancer (Amsterdam, Netherlands)|April 7, 2009
Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case reportMarcello Tiseo, Francesco Gelsomino, Marco Bartolotti, et al.
Pageof 37

Showing results (41-50 of 363) with videos related to

Sort By:
Pageof 37
European Journal of Cancer (Oxford, England : 1990)|April 29, 2020
COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitorsAlessandro Leonetti, Francesco Facchinetti, Teresa Zielli, et al.
Tumori|August 19, 2008
Refractory pleural small cell carcinoma in never smoker. A case reportMarcello Tiseo, Elena Spiritelli, Marzia Capelletti, et al.
Handbook of Experimental Pharmacology|March 24, 2017
Mechanisms of Resistance to Target Therapies in Non-small Cell Lung CancerFrancesco Facchinetti, Claudia Proto, Roberta Minari, et al.
Anticancer Research|June 13, 2014
Gefitinib and afatinib treatment in an advanced non-small cell lung cancer (NSCLC) patient undergoing hemodialysisMelissa Bersanelli, Marcello Tiseo, Fabrizio Artioli, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2021
Letter comments on: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expressionAlessandro Leonetti, Giulia C Giudice, Fabiana Perrone, et al.
Cells|February 15, 2022
Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung CancerKamal Eltayeb, Silvia La Monica, Marcello Tiseo, et al.
Cancers|July 27, 2024
Alectinib in Early-Stage Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Current Evidence and Future ChallengesDiego Luigi Cortinovis, Alessandro Leonetti, Alessandro Morabito, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
K-RAS mutations indicating primary resistance to crizotinib in ALK-rearranged adenocarcinomas of the lung: Report of two cases and review of the literatureMaria Cecilia Mengoli, Fausto Barbieri, Federica Bertolini, et al.
Translational Lung Cancer Research|July 23, 2021
Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysisGiorgia Guaitoli, Marcello Tiseo, Massimo Di Maio, et al.
Lung Cancer (Amsterdam, Netherlands)|April 7, 2009
Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case reportMarcello Tiseo, Francesco Gelsomino, Marco Bartolotti, et al.
Pageof 37